By HU Yuanqiong – Advocates of access to medicines movement would not feel unfamiliar with the issue of patent evergreening on chemical medicines while monopoly could get prolonged through applying for multiple patents on small changes of the same medicine. The similar tricks have also been practiced on other medical products, such as vaccines. As a traditional public health intervention, vaccines have been costing more money in recent years when a couple of newer generation of products are exhausting governments’ budgets largely due to their monopoly situations. Recent researches have suggested that patent thicket and evergreening, among others, have played an instrumental role.
[by Zhao Zhao] On June 14th, 2017, the International Union of Operating Engineers Stationary Engineers Local 39 Health and Welfare Trust Fund, The Detectives’ Endowment Association, Inc., and David Mitchell (“Plaintiffs”) filed a class action antitrust complaint against Celgene Corporation (“Celgene”) over Celgene’s alleged exclusion of competition from the market for two drugs: thalidomide and lenalidomide. Celgene sells them under the brands Thalomid and Revlimid for treating leprosy and multiple myeloma.
The Copyright Amendment (Disability Access and Other Measures) Bill 2017 (the Bill) was passed on Thursday 15 June 2017 and will become law sometime in late December this year (six months from Royal Assent)
The new law includes a number of reforms that have been sought by the education sector for years. These include
[Luisa Guzmán] Last week Fundación Via Libre released a statement urging Argentinian lawmakers to drop a bill proposing a Copyright term extension for photographs, and asking them to open a public debate with the purpose of improving the general conditions for the circulation of cultural goods. To date, over 50 cultural, artistic, and digital rights organizations have signed the statement.
On April 3, 2015, Intellectual Property Watch (IP-Watch) completed its written arguments to the federal district court in Manhattan in a case that could compel the United States Trade Representative (USTR) to release basic information regarding USTR’s negotiations over the proposed Trans-Pacific Partnership (TPP) trade agreement. In particular, IP-Watch’s lawsuit and summary judgment motion asks U.S. District Judge Edgardo Ramos to order USTR to release documents that relate to the intellectual property provisions of the TPP—including USTR’s final negotiating positions, the portions of the draft agreement that the U.S. has proposed or adopted, and communications between USTR and the industry representatives who sit on Industry Trade Advisory Committees (ITACs). Both IP-Watch and USTR have filed opposing summary judgment motions and are now waiting for Judge Ramos to rule on the case.
India, like South Africa, is concerned about the Bilateral Investment Treaties (BITs) it has signed in the past. India has put out a draft its New Model text for BITs negotiations, Now posted online:
The last date for submission of comments is 10th April.
At the following link you will find the FCC’s NPRM for establishing a “retransmission consent” regime online for a specific class of online services called Multichannel Video Programming Distributors. It addresses all services that make multiple linear video programming streams available online on a subscription basis:
On March 5, the Chilean Constitutional Court (CC) decided to review the constitutionality of the patent linkage bill currently being discussed in the Chilean Congress. This bill would set forth a non-merit based preliminary injunction only eligible for pharmaceutical patent holders.